Ranbaxy gets Health Canada nod for generic anti-dementia drug – Economic Times
Economic Times |
Ranbaxy gets Health Canada nod for generic anti-dementia drug
Economic Times NEW DELHI: Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer’s Aricept, a drug used for treatment of dementia in Alzheimer’s patients. The approval by Health Canada is given to … Canada Approves Ranbaxy’s Dementia DrugDrug Discovery & Development Ranbaxy gets approval to market Donepezil tablets in CanadaHindu Business Line |
